loadpatents
name:-0.12220001220703
name:-0.11274790763855
name:-0.029913187026978
Donello; John E. Patent Filings

Donello; John E.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Donello; John E..The latest application filed is for "pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases".

Company Profile
28.167.200
  • Donello; John E. - Dana Point CA
  • Donello; John E. - San Clemente CA
  • - Dana Point CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases
App 20220233505 - Dibas; Mohammed I. ;   et al.
2022-07-28
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20220202777 - Beard; Richard L. ;   et al.
2022-06-30
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
Grant 11,331,306 - Dibas , et al. May 17, 2
2022-05-17
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20220008393 - Dibas; Mohammed I. ;   et al.
2022-01-13
3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof
Grant 11,208,377 - Hein , et al. December 28, 2
2021-12-28
Sulfur derivatives as chemokine receptor modulators
Grant 11,046,644 - Yuan , et al. June 29, 2
2021-06-29
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 10,993,931 - Beard , et al. May 4, 2
2021-05-04
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
Grant 10,899,780 - Beard , et al. January 26, 2
2021-01-26
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases
App 20210008085 - Viswanath; Veena ;   et al.
2021-01-14
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases
App 20210000846 - Viswanath; Veena ;   et al.
2021-01-07
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases
App 20200390747 - Dibas; Mohammed I. ;   et al.
2020-12-17
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20200330428 - Gil; Daniel W. ;   et al.
2020-10-22
Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
Grant 10,799,518 - Viswanath , et al. October 13, 2
2020-10-13
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases
App 20200246360 - Kind Code
2020-08-06
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20200206193 - Dibas; Mohammed I. ;   et al.
2020-07-02
Prostacyclin Receptor Agonists For Reduction Of Body Fat
App 20200171026 - Li; Yong-Xin ;   et al.
2020-06-04
Sulfur Derivatives As Chemokine Receptor Modulators
App 20200109110 - YUAN; HAIQING ;   et al.
2020-04-09
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
Grant 10,555,933 - Dibas , et al. Feb
2020-02-11
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20190343804 - Beard; Richard L. ;   et al.
2019-11-14
Use of agonists of formyl peptide receptor 2 for treating dermatological diseases
Grant 10,434,112 - Viswanath , et al. O
2019-10-08
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases
App 20190240200 - Dibas; Mohammed I. ;   et al.
2019-08-08
Compositions Including Encapsulated Isotretinoin And Methods For Use Thereof
App 20190192467 - Donello; John E. ;   et al.
2019-06-27
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Ocular Inflammatory Diseases
App 20190153004 - Beard; Richard L. ;   et al.
2019-05-23
Sulfur derivatives as chemokine receptor modulators
Grant 10,287,243 - Yuan , et al.
2019-05-14
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
Grant 10,251,865 - Gil , et al.
2019-04-09
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
Grant 10,208,071 - Beard , et al. Feb
2019-02-19
3,4-disubstituted 3-cyclobutene-1,2-diones And Use Thereof
App 20190047947 - Hein; Christopher D. ;   et al.
2019-02-14
Pharmaceutical compositions comprising 7-(1H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Grant 10,201,535 - Dibas , et al. Feb
2019-02-12
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 10,172,832 - Beard , et al. J
2019-01-08
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20180344692 - Gil; Daniel W. ;   et al.
2018-12-06
Compositions including encapsulated isotretinoin and methods for use thereof
Grant 10,123,988 - Donello , et al. November 13, 2
2018-11-13
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20180228772 - Beard; Richard L. ;   et al.
2018-08-16
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 9,974,772 - Beard , et al. May 22, 2
2018-05-22
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20180071259 - Gil; Daniel W. ;   et al.
2018-03-15
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20180071260 - Gil; Daniel W. ;   et al.
2018-03-15
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
Grant 9,902,710 - Leblond , et al. February 27, 2
2018-02-27
Alpha-2 adrenergic agonist having long duration of intraocular pressure-lowering effect
Grant 9,889,088 - Dibas , et al. February 13, 2
2018-02-13
Carbamoyl hydrazine derivatives as formyl peptide modulators
Grant 9,868,700 - Vuligonda , et al. January 16, 2
2018-01-16
Methods of treating .alpha. adrenergic mediated conditions
Grant 9,849,113 - Gil , et al. December 26, 2
2017-12-26
Use of agonists of formyl peptide receptor 2 for treating ocular inflammatory diseases
Grant 9,850,264 - Beard , et al. December 26, 2
2017-12-26
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
Grant 9,828,349 - Leblond , et al. November 28, 2
2017-11-28
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Ocular Inflammatory Diseases
App 20170320897 - Beard; Richard L. ;   et al.
2017-11-09
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases
App 20170216326 - Viswanath; Veena ;   et al.
2017-08-03
Carbamoyl Hydrazine Derivatives As Formyl Peptide Modulators
App 20170183298 - Vuligonda; Vidyasagar ;   et al.
2017-06-29
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20170182028 - Dibas; Mohammed I. ;   et al.
2017-06-29
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20170172982 - Gil; Daniel W. ;   et al.
2017-06-22
D-serine For The Treatment Of Visual System Disorders
App 20170172959 - Li; Yong-Xin ;   et al.
2017-06-22
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20170172983 - Dibas; Mohammed I. ;   et al.
2017-06-22
(2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
Grant 9,670,150 - Beard , et al. June 6, 2
2017-06-06
Pyridinyl and pyrimidinyl sulfonamide derivatives as chemokine receptor modulators
Grant 9,670,190 - Beard , et al. June 6, 2
2017-06-06
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
Grant 9,670,181 - Leblond , et al. June 6, 2
2017-06-06
Carbamoyl hydrazine derivatives as formyl peptide modulators
Grant 9,663,457 - Beard , et al. May 30, 2
2017-05-30
Sulfur derivatives as chemokine receptor modulators
Grant 9,663,460 - Yuan , et al. May 30, 2
2017-05-30
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20170119737 - Beard; Richard L. ;   et al.
2017-05-04
Treatment of inflammatory bowel disease
Grant 9,637,467 - Donde , et al. May 2, 2
2017-05-02
Methods of treating .alpha. adrenergic mediated conditions
Grant 9,623,006 - Gil , et al. April 18, 2
2017-04-18
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20170095466 - Dibas; Mohammed I. ;   et al.
2017-04-06
1,2- bis-sulfonamide derivatives as chemokine receptor modulators
Grant 9,603,834 - Yuan , et al. March 28, 2
2017-03-28
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20170079956 - Gil; Daniel W. ;   et al.
2017-03-23
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 9,579,307 - Beard , et al. February 28, 2
2017-02-28
Sulfur Derivatives As Chemokine Receptor Modulators
App 20170050925 - YUAN; HAIQING ;   et al.
2017-02-23
Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators
Grant 9,550,746 - Yuan , et al. January 24, 2
2017-01-24
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
Grant 9,545,394 - Gil , et al. January 17, 2
2017-01-17
Alpha adrenergic receptor modulators
Grant 9,522,150 - Chow , et al. December 20, 2
2016-12-20
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions
App 20160354346 - Dibas; Mohammed I. ;   et al.
2016-12-08
Compositions for treating cognitive disorders
Grant 9,492,543 - Staubli , et al. November 15, 2
2016-11-15
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3himidazole Derivatives For Treating Retinal Diseases
App 20160303083 - Dibas; Mohammed I. ;   et al.
2016-10-20
Substituted 6, 7-dialkoxy-3-isoquinoline Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a)
App 20160264549 - Leblond; Bertrand ;   et al.
2016-09-15
Derivatives of N-urea substituted amino acids as formyl peptide receptor modulators
Grant 9,428,549 - Beard , et al. August 30, 2
2016-08-30
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20160235711 - Beard; Richard L. ;   et al.
2016-08-18
Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators
Grant 9,416,120 - Yuan , et al. August 16, 2
2016-08-16
Novel 1,2- Bis-sulfonamide Derivatives As Chemokine Receptor Modulators
App 20160228407 - Yuan; Haiqing ;   et al.
2016-08-11
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
Grant 9,399,628 - Leblond , et al. July 26, 2
2016-07-26
Sulfur derivatives as chemokine receptor modulators
Grant 9,371,278 - Yuan , et al. June 21, 2
2016-06-21
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20160158199 - Gil; Daniel W. ;   et al.
2016-06-09
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20160151349 - Dibas; Mohammed I. ;   et al.
2016-06-02
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 9,351,948 - Beard , et al. May 31, 2
2016-05-31
Sulfur derivatives as chemokine receptor modulators
Grant 9,328,067 - Yuan , et al. May 3, 2
2016-05-03
Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
Grant 9,314,466 - Donello , et al. April 19, 2
2016-04-19
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Grant 9,308,201 - Dibas , et al. April 12, 2
2016-04-12
Treatment Of Inflammatory Bowel Disease
App 20160096817 - Donde; Yariv ;   et al.
2016-04-07
Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
Grant 9,303,021 - Donello , et al. April 5, 2
2016-04-05
Sulfur Derivatives As Chemokine Receptor Modulators
App 20160083342 - YUAN; HAIQING ;   et al.
2016-03-24
1-aryl-1-hydroxy-2,3-diamino-propyl Amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20160083371 - Leblond; Bertrand ;   et al.
2016-03-24
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
Grant 9,289,420 - Gil , et al. March 22, 2
2016-03-22
Pharmaceutical compositions comprising 7-(1 H-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions
Grant 9,283,217 - Dibas , et al. March 15, 2
2016-03-15
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20160067222 - Dibas; Mohammed I. ;   et al.
2016-03-10
Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
Grant 9,278,943 - Leblond , et al. March 8, 2
2016-03-08
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8- Tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20160051534 - Dibas; Mohammed I. ;   et al.
2016-02-25
Methods For Treating Cognitive Disorders Using 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds
App 20160051555 - Donello; John E. ;   et al.
2016-02-25
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
Grant 9,200,016 - Leblond , et al. December 1, 2
2015-12-01
Carbamoyl Hydrazine Derivatives As Formyl Peptide Modulators
App 20150291511 - Beard; Richard L. ;   et al.
2015-10-15
Treatment of inflammatory bowel disease
Grant 9,156,810 - Donde , et al. October 13, 2
2015-10-13
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3himidazole Derivatives For Treating Retinal Diseases
App 20150250764 - Dibas; Mohammed I. ;   et al.
2015-09-10
Methods For Treating Cognitive Disorders Using 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds
App 20150231140 - Donello; John E. ;   et al.
2015-08-20
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20150231128 - Dibas; Mohammed I. ;   et al.
2015-08-20
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20150224080 - Gil; Daniel W. ;   et al.
2015-08-13
Benzofuran-2-sulfonamides Derivatives As Chemokine Receptor Modulators
App 20150218119 - YUAN; HAIQING ;   et al.
2015-08-06
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3H-imidazole derivatives for treating retinal diseases
Grant 9,095,576 - Dibas , et al. August 4, 2
2015-08-04
Alpha Adrenergic Receptor Modulators
App 20150209351 - Chow; Ken ;   et al.
2015-07-30
Aromatic bycyclic derivatives as CXCR4 receptor modulators
Grant 9,090,624 - Vuligonda , et al. July 28, 2
2015-07-28
Substituted 6, 7-dialkoxy-3-isoquinoline Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a)
App 20150158895 - Leblond; Bertrand ;   et al.
2015-06-11
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20150148395 - Beard; Richard L. ;   et al.
2015-05-28
Alpha adrenergic receptor modulators
Grant 9,040,532 - Chow , et al. May 26, 2
2015-05-26
Methods of treating alpha adrenergic mediated conditions
Grant 9,034,910 - Gil , et al. May 19, 2
2015-05-19
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,993,780 - Beard , et al. March 31, 2
2015-03-31
Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Modulators
App 20150025021 - Beard; Richard L. ;   et al.
2015-01-22
Treatment Of Inflammatory Bowel Disease
App 20150018400 - DONDE; YARIV ;   et al.
2015-01-15
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity
Grant 8,927,589 - Leblond , et al. January 6, 2
2015-01-06
Benzofuran-2-sulfonamides derivatives as chemokine receptor modulators
Grant 8,927,544 - Yuan , et al. January 6, 2
2015-01-06
Sulfur Derivatives As Chemokine Receptor Modulators
App 20140378492 - YUAN; HAIQING ;   et al.
2014-12-25
Benzofuran-2-sulfonamides Pyridine Derivatives As Chemokine Receptor Modulators
App 20140329813 - Yuan; Haiqing ;   et al.
2014-11-06
Sulfur derivatives as chemokine receptor modulators
Grant 8,877,804 - Yuan , et al. November 4, 2
2014-11-04
Substituted 6,7-dialkoxy-3-isoquinolinol Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a)
App 20140309253 - Leblond; Bertrand ;   et al.
2014-10-16
Ester pro-drugs of [3-(1-(1H-imidazol-4-YL)ethyl)-2-methylphenyl] methanol for treating retinal diseases
Grant 8,853,251 - Dibas , et al. October 7, 2
2014-10-07
Methods For Treating Cognitive Disorders Using 3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds
App 20140296287 - Donello; John E. ;   et al.
2014-10-02
Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,846,760 - Beard , et al. September 30, 2
2014-09-30
Compositions Including Encapsulated Isotretinoin And Methods For Use Thereof
App 20140271875 - Donello; John E. ;   et al.
2014-09-18
Alpha-2 Adrenergic Agonist For Treating Intraocular Pressure And Ocular Diseases Through Intravitreal And Intracameral Routes
App 20140275197 - DIBAS; Mohammed I. ;   et al.
2014-09-18
Pyridinyl And Pyrimidinyl Sulfonamide Derivatives As Chemokine Receptor Modulators
App 20140275132 - Beard; Richard L. ;   et al.
2014-09-18
Compounds having analgesic and/or immunostimulant activity
Grant 8,835,463 - Leblond , et al. September 16, 2
2014-09-16
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Ocular Inflammatory Diseases
App 20140256684 - Beard; Richard L. ;   et al.
2014-09-11
Use Of Agonists Of Formyl Peptide Receptor 2 For Treating Dermatological Diseases
App 20140256685 - Beard; Richard L. ;   et al.
2014-09-11
Sulfur derivatives as chemokine receptor modulators
Grant 8,822,530 - Yuan , et al. September 2, 2
2014-09-02
Benzofuran-2-sulfonamides pyridine derivatives as chemokine receptor modulators
Grant 8,815,915 - Yuan , et al. August 26, 2
2014-08-26
Aryl urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,816,076 - Beard , et al. August 26, 2
2014-08-26
1-1-Oxo-1,2,3,4-tetrahydroisoquinolin-7-yl)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,809,367 - Beard , et al. August 19, 2
2014-08-19
Sulfur Derivatives As Chemokine Receptor Modulators
App 20140221481 - YUAN; HAIQING ;   et al.
2014-08-07
Novel 1,2- Bis-sulfonamide Derivatives As Chemokine Receptor Modulators
App 20140221351 - YUAN; HAIQING ;   et al.
2014-08-07
Sulfur derivatives as chemokine receptor modulators
Grant 8,791,161 - Yuan , et al. July 29, 2
2014-07-29
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
Grant 8,772,316 - Leblond , et al. July 8, 2
2014-07-08
Methods For Treating Cognitive Disorders Using 3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds
App 20140179925 - Donello; John E. ;   et al.
2014-06-26
Geminal dialkyl prostanoids
Grant 8,754,122 - Donde , et al. June 17, 2
2014-06-17
Imidazolidine-2,4-dione derivatives as N-formyl peptide receptor 2 modulators
Grant 8,729,096 - Beard , et al. May 20, 2
2014-05-20
1,2- bis-sulfonamide derivatives as chemokine receptor modulators
Grant 8,729,066 - Yuan , et al. May 20, 2
2014-05-20
Treating ocular diseases using peroxisome proliferator--activated receptor delta antagonists
Grant 8,729,042 - Rodrigues , et al. May 20, 2
2014-05-20
Dihydronaphthalene And Naphthalene Derivatives As N-formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20140128471 - Beard; Richard L. ;   et al.
2014-05-08
Therapeutic Quinoline And Naphthalene Derivatives
App 20140107153 - Beard; Richard L. ;   et al.
2014-04-17
Methods For Treating Cognitive Disorders
App 20140107158 - Donello; John E. ;   et al.
2014-04-17
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20140094614 - Beard; Richard L. ;   et al.
2014-04-03
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20140066483 - Gil; Daniel W. ;   et al.
2014-03-06
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Retinal Diseases
App 20140057958 - DIBAS; Mohammed I. ;   et al.
2014-02-27
Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,658,803 - Beard , et al. February 25, 2
2014-02-25
Novel 1,2- Bis-sulfonamide Derivatives As Chemokine Receptor Modulators
App 20140051682 - Yuan; Haiqing ;   et al.
2014-02-20
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating retinal diseases
Grant 8,653,123 - Dibas , et al. February 18, 2
2014-02-18
Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,653,299 - Vuligonda , et al. February 18, 2
2014-02-18
Methods for treating cognitive disorders
Grant 8,629,165 - Donello , et al. January 14, 2
2014-01-14
S1p3 Receptor Inhibitors For Treating Pain
App 20140011771 - Donello; John E. ;   et al.
2014-01-09
Methods for treating cognitive disorders using 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds
Grant 8,623,891 - Donello , et al. January 7, 2
2014-01-07
Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
Grant 08618163 -
2013-12-31
Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
Grant 8,618,163 - Beard , et al. December 31, 2
2013-12-31
Therapeutic quinoline and naphthalene derivatives
Grant 8,614,326 - Beard , et al. December 24, 2
2013-12-24
Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
App 20130338187 - Beard; Richard L. ;   et al.
2013-12-19
6-substituted Indole-3-carboxylic Acid Amide Compounds Having Sphingosine-1-phosphate (s1p) Receptor Antagonist Biological Activity
App 20130338158 - Beard; Richard L. ;   et al.
2013-12-19
Aryl Urea Derivatives As N-formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20130331570 - Beard; Richard L. ;   et al.
2013-12-12
1-aryl -1-hydroxy -2,3-diamino-propyl Amin Es, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20130310383 - Leblond; Bertrand ;   et al.
2013-11-21
1-(1-OXO-1,2,3,4-tetrahydroisoquinolin-7-YL)urea derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,580,817 - Beard , et al. November 12, 2
2013-11-12
1,2-bis-sulfonamide derivatives as chemokine receptor modulators
Grant 8,580,779 - Yuan , et al. November 12, 2
2013-11-12
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions
App 20130296394 - Dibas; Mohammed I. ;   et al.
2013-11-07
Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
Grant 8,575,207 - Gil , et al. November 5, 2
2013-11-05
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Lowering Intraocular Pressure
App 20130289088 - Dibas; Mohammed I. ;   et al.
2013-10-31
S1P3 receptor inhibitors for treating pain
Grant 8,563,594 - Donello , et al. October 22, 2
2013-10-22
(2-ureidoacetamido)alkyl Derivatives As Formyl Peptide Receptor 2 Modulators
App 20130274230 - Beard; Richard L. ;   et al.
2013-10-17
Sulfur Derivatives As Chemokine Receptor Modulators
App 20130252984 - YUAN; Haiqing ;   et al.
2013-09-26
Aryl urea derivatives as N-formyl peptide receptors like-1 (FPRL-1) receptor modulators
Grant 8,541,577 - Beard , et al. September 24, 2
2013-09-24
Sulfur Derivatives As Chemokine Receptor Modulators
App 20130237552 - YUAN; HAIQING ;   et al.
2013-09-12
Benzofuran-2-sulfonamides Pyridine Derivatives As Chemokine Receptor Modulators
App 20130231339 - YUAN; HAIQING ;   et al.
2013-09-05
Benzofuran-2-sulfonamides Derivatives As Chemokine Receptor Modulators
App 20130231338 - YUAN; HAIQING ;   et al.
2013-09-05
Benzisothiazol-3(1H)-one-5-sulfonyl derivatives as chemokine receptor modulators
Grant 8,524,745 - Yuan , et al. September 3, 2
2013-09-03
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
Grant 8,524,917 - Beard , et al. September 3, 2
2013-09-03
Phosphorous derivatives as chemokine receptor modulators
Grant 8,518,913 - Yuan , et al. August 27, 2
2013-08-27
Imidazolidine-2,4-dione Derivatives As N-formyl Peptide Receptor 2 Modulators
App 20130217720 - Beard; Richard L. ;   et al.
2013-08-22
Method Of Reducing The Severity Of Inflammatory Dermatological Conditions
App 20130217694 - Gil; Daniel W. ;   et al.
2013-08-22
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
Grant 8,513,288 - Leblond , et al. August 20, 2
2013-08-20
Alpha-2 Adrenergic Agonist Having Long Duration Of Intraocular Pressure-lowering Effect
App 20130210876 - DONELLO; JOHN E. ;   et al.
2013-08-15
Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1H)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (FPRL-1) agonist or antagonist activity
Grant 8,507,560 - Beard , et al. August 13, 2
2013-08-13
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20130203809 - Dibas; Mohammed I. ;   et al.
2013-08-08
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-aminopropionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20130202653 - Leblond; Bertrand ;   et al.
2013-08-08
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for lowering intraocular pressure
Grant 8,501,796 - Dibas , et al. August 6, 2
2013-08-06
Brimonidine For Treating Visual Disorders Mediated By Central Visual Projections From The Eye
App 20130197002 - Staubli; Ursula ;   et al.
2013-08-01
Sulfur Derivatives As Chemokine Receptor Modulators
App 20130190338 - YUAN; HAIQING ;   et al.
2013-07-25
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol for treating skin diseases and conditions
Grant 8,492,422 - Dibas , et al. July 23, 2
2013-07-23
2,5-Dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,492,556 - Beard , et al. July 23, 2
2013-07-23
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
Grant 8,492,557 - Chow , et al. July 23, 2
2013-07-23
Sulfur Derivatives As Chemokine Receptor Modulators
App 20130165460 - YUAN; Haiqing ;   et al.
2013-06-27
Benzisothiazol-3(1h)-one-5-sulfonyl Derivatives As Chemokine Receptor Modulators
App 20130150413 - Yuan; Haiqing ;   et al.
2013-06-13
Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists
Grant 8,455,548 - Luhrs , et al. June 4, 2
2013-06-04
Method Of Treating Sensorimotor Disorders With Alpha-2 Adrenergic Receptor Agonists
App 20130137725 - Luhrs; Lauren M.B. ;   et al.
2013-05-30
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Retinal Neuroprotection
App 20130137724 - Dibas; Mohammed I. ;   et al.
2013-05-30
Sulfur derivatives as chemokine receptor modulators
Grant 8,450,367 - Yuan , et al. May 28, 2
2013-05-28
Pharmaceutical Compositions Comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole Derivatives For Treating Retinal Diseases
App 20130131133 - Dibas; Mohammed I. ;   et al.
2013-05-23
Pharmaceutical Compositions Comprising 7-(1h-imidazol-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline For Treating Skin Diseases And Conditions
App 20130123303 - Dibas; Mohammed I. ;   et al.
2013-05-16
Aryl Urea Derivatives As N-formyl Peptide Receptors Like-1 (fprl-1) Receptor Modulators
App 20130123496 - Beard; Richard L. ;   et al.
2013-05-16
2,5-dioxoimidazolidin-1-yl-3-phenylurea Derivatives As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20130123215 - Beard; Richard L. ;   et al.
2013-05-16
Polycyclic pyrrolidine-2,5-dione derivatives as -formyl peptide receptor like-1 (FPRL-1) receptor modulators
Grant 8,440,684 - Beard , et al. May 14, 2
2013-05-14
Amide Derivatives Of N-urea Substituted Amino Acids As Formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20130109866 - Beard; Richard L. ;   et al.
2013-05-02
Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
Grant 8,431,702 - Sinha , et al. April 30, 2
2013-04-30
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
Grant 8,431,599 - Leblond , et al. April 30, 2
2013-04-30
Topical Dermal Brimonidine Compositions
App 20130102612 - Gil; Daniel W. ;   et al.
2013-04-25
Compositions and methods for treating seizure disorders
Grant 8,404,721 - Donello , et al. March 26, 2
2013-03-26
Pharmaceutical Compositions Comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine For Treating Retinal Diseases
App 20130046003 - Dibas; Mohammed I. ;   et al.
2013-02-21
Compositiions For Treating Cognitive Disorders
App 20130040938 - Stabuli; Ursula V. ;   et al.
2013-02-14
Aromatic Bycyclic Derivatives As Cxcr4 Receptor Modulators
App 20130035347 - Vuligonda; Vidyasagar ;   et al.
2013-02-07
Alpha-2 Adrenergic Modulators For Treating Visual Disorders Mediated By Central Visual Projections From The Eye
App 20130023573 - Staubli; Ursula V. ;   et al.
2013-01-24
Pharmaceutical Compositions Comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine For Treating Skin Diseases
App 20130023572 - Dibas; Mohammed I. ;   et al.
2013-01-24
Polycyclic Pyrrolidine-2,5-dione Derivatives As -formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20130018067 - Beard; Richard L. ;   et al.
2013-01-17
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20130005717 - Leblond; Bertrand ;   et al.
2013-01-03
D-serine For The Treatment Of Visual System Disorders
App 20120329873 - Li; YONG-XIN ;   et al.
2012-12-27
Targeted Delivery of Retinoid Compounds to the Sebaceous Glands
App 20120328670 - Donello; John E. ;   et al.
2012-12-27
THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
App 20120309782 - Sinha; Santosh C. ;   et al.
2012-12-06
Methods of Preventing and Reducing the Severity of Stress-Associated Conditions
App 20120302574 - Gil; Daniel W. ;   et al.
2012-11-29
Compositions And Methods For Treating Seizure Disorders
App 20120295936 - Donello; John E. ;   et al.
2012-11-22
Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
Grant 8,309,729 - Sinha , et al. November 13, 2
2012-11-13
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
Grant 8,288,556 - Leblond , et al. October 16, 2
2012-10-16
Dihydronaphthalene And Naphthalene Derivatives As N-formyl Peptide Receptor Like-1 (fprl-1) Receptor Modulators
App 20120238628 - Vuligonda; Vidyasagar ;   et al.
2012-09-20
Methods Of Using As Analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl Amines, 3-benzyl-3-hyrdroxy-2-amino-propionic Acid Amides And Related Compounds
App 20120225881 - Leblond; Bertrand ;   et al.
2012-09-06
THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
App 20120214838 - Sinha; Santosh C. ;   et al.
2012-08-23
Methods For Treating Diseases Of The Retina
App 20120214842 - Donello; John E. ;   et al.
2012-08-23
Substituted 6,7-dialkoxy-3-isoquinolinol Derivatives As Inhibitors Of Phosphodiesterase 10 (pde10a)
App 20120214837 - Leblond; Bertrand ;   et al.
2012-08-23
Novel 1-(1-OXO-1,2,3,4-TETRAHYDROISOQUINOLIN-7-YL)Urea Derivatives As N-FORMYL Peptide Receptor Like-1 (FPRL-1) Receptor Modulators
App 20120208842 - Beard; Richard L. ;   et al.
2012-08-16
Alpha Adrenergic Receptor Modulators
App 20120208821 - Chow; Ken ;   et al.
2012-08-16
Compositions and methods for treating seizure disorders
Grant 8,242,141 - Donello , et al. August 14, 2
2012-08-14
Unsubstituted And Substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones Acting As Specific Or Selective Alpha2 Adrenergic Agonists And Methods For Using The Same
App 20120196911 - Heidelbaugh; Todd M. ;   et al.
2012-08-02
Methods Of Treating Motor Disorders With Alpha-2b Andrenergic Receptor Agonists
App 20120190719 - Gil; Daniel W. ;   et al.
2012-07-26
Methods for Treating Cognitive Disorders
App 20120190712 - Donello; John E. ;   et al.
2012-07-26
Compositions and methods for treating spasticity
Grant 8,217,059 - Gil , et al. July 10, 2
2012-07-10
Methods for treating anxiety
Grant 8,211,917 - Donello , et al. July 3, 2
2012-07-03
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20120165380 - Gil; Daniel W. ;   et al.
2012-06-28
Compounds Having Analgesic And/or Immunostimulant Activity
App 20120157497 - Leblond; Bertrand ;   et al.
2012-06-21
Novel 1,2- Bis-sulfonamide Derivatives As Chemokine Receptor Modulators
App 20120157444 - Yuan; Haiqing ;   et al.
2012-06-21
Sulfur Derivatives As Chemokine Receptor Modulators
App 20120157487 - Yuan; Haiqing ;   et al.
2012-06-21
Phosphorous Derivatives As Chemokine Receptor Modulators
App 20120157413 - Yuan; Haiqing ;   et al.
2012-06-21
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Retinal Diseases
App 20120149746 - Dibas; Mohammed I. ;   et al.
2012-06-14
Pharmaceutical Compositions Comprising (3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl)methanol
App 20120149747 - Dibas; Mohammad I. ;   et al.
2012-06-14
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Lowering Intraocular Pressure
App 20120142746 - Dibas; Mohammed I. ;   et al.
2012-06-07
Pharmaceutical Compositions Comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea Derivatives Having Formyl Peptide Receptor Like-1 (fprl-1) Agonist Or Antagonist Activity
App 20120142726 - Beard; Richard L. ;   et al.
2012-06-07
Bicyclic compounds having activity at the CXCR4 receptor
Grant 8,193,203 - Beard , et al. June 5, 2
2012-06-05
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol For Treating Skin Diseases And Conditions
App 20120136036 - Dibas; Mohammed I. ;   et al.
2012-05-31
Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists
App 20120136041 - Rodrigues; Gerard A. ;   et al.
2012-05-31
Therapeutically useful substituted hydropyrido [3,2,1-ij] quinoline compounds
Grant 8,188,279 - Sinha , et al. May 29, 2
2012-05-29
Ester Pro-drugs Of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] Methanol
App 20120122945 - Chow; Ken ;   et al.
2012-05-17
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha.sub.2 adrenergic agonists and methods for using the same
Grant 8,178,571 - Heidelbaugh , et al. May 15, 2
2012-05-15
Methods for treating cognitive disorders
Grant 8,173,683 - Donello , et al. May 8, 2
2012-05-08
3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
Grant 8,168,631 - Leblond , et al. May 1, 2
2012-05-01
Compounds having analgesic and/or immunostimulant activity
Grant 8,153,666 - Leblond , et al. April 10, 2
2012-04-10
Treating pain using selective antagonists of persistent sodium current
Grant 8,153,645 - Ehring , et al. April 10, 2
2012-04-10
Alpha-2b Receptor Agonist And Anticonvulsant Compositions For Treating Chronic Pain
App 20120083508 - Gil; Daniel W. ;   et al.
2012-04-05
Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
Grant 8,143,291 - Beard , et al. March 27, 2
2012-03-27
S1P3 Receptor Inhibitors for Treating Conditions of the Eye
App 20120071448 - Donello; John E. ;   et al.
2012-03-22
Method Of Activating Regulatory T Cells With Alpha-2b Adrenergic Receptor Agonists
App 20120041031 - Gil; Daniel W. ;   et al.
2012-02-16
Methods Of Treating Alpha Adrenergic Mediated Conditions
App 20120035235 - Fang; Wenkui K. ;   et al.
2012-02-09
Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist
Grant 8,097,644 - Beard , et al. January 17, 2
2012-01-17
Compositions and Methods for the Treatment of Ophthalmic Disease
App 20120003275 - Rodrigues; Gerard A. ;   et al.
2012-01-05
Derivatives Of Cycloalkyl- And Cycloalkenyl-1,2-dicarboxylic Acid Compounds Having Formyl Peptide Receptor Like-1 (fprl-1) Agonist Or Antagonist Activity
App 20110319454 - Beard; Richard L. ;   et al.
2011-12-29
Methods of treating alpha adrenergic mediated conditions
Grant 8,071,636 - Fang , et al. December 6, 2
2011-12-06
1-aryl-1-hydroxy-2,3-diamino-propyl Amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20110288094 - Leblond; Bertrand ;   et al.
2011-11-24
Indole Compounds Bearing Aryl Or Heteroaryl Groups Having Sphingosine-1-phosphate (s1p) Receptor Biological Activity
App 20110275677 - Beard; Richard L. ;   et al.
2011-11-10
Method Of Treating Sensorimotor Disorders With 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
App 20110269805 - Gil; Daniel W. ;   et al.
2011-11-03
THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
App 20110237797 - Sinha; Santosh C. ;   et al.
2011-09-29
Nonsedating .alpha.-2 agonists
Grant 8,022,226 - Chow , et al. September 20, 2
2011-09-20
3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity
Grant 8,013,000 - Leblond , et al. September 6, 2
2011-09-06
Compositions And Methods For Treating Spasticity
App 20110212995 - Gil; Daniel W. ;   et al.
2011-09-01
Alpha-2 Adrenergic Agonist Having Long Duration Ofintraocular Pressure-lowering Effect
App 20110178145 - Donello; John E. ;   et al.
2011-07-21
Treatment Of Inflammatory Bowel Disease
App 20110172435 - Donde; Yariv ;   et al.
2011-07-14
Methods of preventing and reducing the severity of stress-associated conditions
Grant 7,977,335 - Gil , et al. July 12, 2
2011-07-12
Method Of Treating Motor Disorders With Alpha-2b Adrenergic Receptor Agonists
App 20110160265 - Luhrs; Lauren M.B. ;   et al.
2011-06-30
Compositions and methods for the treatment of ophthalmic disease
Grant 7,964,191 - Rodrigues , et al. June 21, 2
2011-06-21
Pyrrole Compounds Having Sphingosine-1-Phosphate Receptor Agonist Or Antagonist Biological Activity
App 20110105567 - Beard; Richard L. ;   et al.
2011-05-05
Compositions And Methods For Treating Disorders Of Gastrointestinal Motility
App 20110065748 - Donello; John E.
2011-03-17
Compositions And Methods For Treating Seizure Disorders
App 20110065747 - Donello; John E. ;   et al.
2011-03-17
Therapeutic Quinoline And Naphthalene Derivatives
App 20110046177 - Beard; Richard L. ;   et al.
2011-02-24
Ccr2 Inhibitors For Treating Conditions Of The Eye
App 20110038871 - Viswanth; Veena ;   et al.
2011-02-17
Isothiozoles For Treating Conditions Of The Eye
App 20110039900 - Viswanath; Veena ;   et al.
2011-02-17
Indole compounds bearing aryl or heteroaryl groups having sphingosine 1-phosphate (S1P) receptor biological activity
Grant 7,888,336 - Beard , et al. February 15, 2
2011-02-15
Nonsedating Alpha-2 Agonists
App 20110034525 - Chow; Ken ;   et al.
2011-02-10
Methods and compositions for the treatment of pain and other neurological conditions
Grant 7,884,115 - Donello , et al. February 8, 2
2011-02-08
Compositions For Treating Cognitive Disorders
App 20110015179 - Staubli; Ursula V. ;   et al.
2011-01-20
S1p3 Receptor Inhibitors For Treating Inflammation
App 20110009453 - Donello; John E. ;   et al.
2011-01-13
Treatment of inflammatory bowel disease
Grant 7,855,226 - Donde , et al. December 21, 2
2010-12-21
Unsubstituted And Substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones Acting As Specific Or Selective Alpha2 Adrenergic Agonists And Methods For Using The Same
App 20100298395 - Heidelbaugh; Todd M. ;   et al.
2010-11-25
4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
Grant 7,838,545 - Heidelbaugh , et al. November 23, 2
2010-11-23
S1p3 Receptor Inhibitors For Treating Pain
App 20100249069 - Donello; John E. ;   et al.
2010-09-30
Method Of Treating Sensorimotor Disorders With Alpha-2 Adrenergic Receptor Agonists
App 20100240699 - Luhrs; Lauren M.B. ;   et al.
2010-09-23
Indole Compounds Bearing Aryl or Heteroaryl Groups Having Sphingosine 1-Phosphate (S1P) Receptor Biological Activity
App 20100240614 - Beard; Richard L. ;   et al.
2010-09-23
Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same
Grant 7,795,292 - Heidelbaugh , et al. September 14, 2
2010-09-14
Method Of Treating Motor Disorders With 4-(1-(2,3-dimethylphenyl)ethyl)-1h-imidazole-2(3h)-thione
App 20100216857 - Luhrs; Lauren M.B. ;   et al.
2010-08-26
Methods For Treating Anxiety
App 20100197730 - Donello; John E. ;   et al.
2010-08-05
Treating pain using selective antagonists of persistent sodium current
Grant 7,767,718 - Ehring , et al. August 3, 2
2010-08-03
Methods For Treating Cognitive Disorders Using 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds
App 20100190792 - Donello; John E. ;   et al.
2010-07-29
Treating pain using selective antagonists of persistent sodium current
Grant 7,763,651 - Ehring , et al. July 27, 2
2010-07-27
Treating Ocular Diseases Using Peroxisome Proliferator-Activated Receptor Delta Antagonists
App 20100183696 - Rodrigues; Gerard A. ;   et al.
2010-07-22
Indole-3-carboxylic acid amide, ester, thioamide and thiol ester compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
Grant 7,737,173 - Beard , et al. June 15, 2
2010-06-15
Heteroaromatic compounds having sphingosine-1-phosphate (S1P) receptor agonist biological activity
Grant 7,728,014 - Beard , et al. June 1, 2
2010-06-01
Methods For Treating Cognitive Disorders Using 1-aryl-1-hydroxy-2,3-diamino-propyl Amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds
App 20100105687 - Donello; John E. ;   et al.
2010-04-29
Methods For Treating Cognitive Disorders Using 3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds
App 20100093793 - Donello; John E. ;   et al.
2010-04-15
Substituted 3-amino-1-oxo Or Thioxo-1,2,5,6,7,8-hexahydro-2,7-naphthyridine-4-carbonitriles Are Selective Alpha 2b Antagonists
App 20100076194 - CAPPIELLO; John R. ;   et al.
2010-03-25
4-(Phenylmethyl and substituted phenylmethyl)-imidazole-2-thiones acting as specific alpha2 adrenergic agonists
Grant 7,683,089 - Heidelbaugh , et al. March 23, 2
2010-03-23
Methods For Treating Cognitive Disorders
App 20100048642 - Donello; John E. ;   et al.
2010-02-25
Alpha-2 Receptor Pan Agonist And Anticonvulsant Compositions For Treating Chronic Pain
App 20100029618 - Gil; Daniel W. ;   et al.
2010-02-04
Methods for detecting receptor modulator activity
Grant 7,655,396 - Kedzie , et al. February 2, 2
2010-02-02
Alpha-2b Adrenergic Receptor Agonist And Serotonin-norepinephrine Reuptake Inhibitor Compositions For Treating Chronic Pain
App 20100016355 - Gil; Daniel W. ;   et al.
2010-01-21
THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS
App 20100009985 - SINHA; Santosh C. ;   et al.
2010-01-14
Compounds Having Analgesic And/or Immunostimulant Activity
App 20090318499 - Leblond; Bertrand ;   et al.
2009-12-24
Bicyclic Compounds Having Activity At The Cxcr4 Receptor
App 20090312305 - Beard; Richard L. ;   et al.
2009-12-17
THERAPEUTICALLY USEFUL SUBSTITUTED 1,7-DIPHENYL-1,2,3,5,6,7-HEXAHYDROPYRIDO[3,2,1-Ij]QUINOLINE COMPOUNDS
App 20090281322 - Sinha; Santosh C. ;   et al.
2009-11-12
3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic Activity
App 20090281085 - Leblond; Bertrand ;   et al.
2009-11-12
4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-- 2-thione as specific alpha.sub.2b agonist and methods of using the same
Grant 7,569,584 - Heidelbaugh , et al. August 4, 2
2009-08-04
4-(condensed Cyclicmethyl)-imidazole-2-thiones Acting As Alpha2 Adrenergic Agonists
App 20090176828 - Heidelbaugh; Todd M. ;   et al.
2009-07-09
Methods Of Using As Analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds
App 20090088433 - Leblond; Bertrand ;   et al.
2009-04-02
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20090036436 - Leblond; Bertrand ;   et al.
2009-02-05
3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity
App 20080312236 - Leblond; Bertrand ;   et al.
2008-12-18
4-(heteroaryl-methyl And Substituted Heteroaryl-methyl)-imidazole-2-thiones Acting As Alpha2 Adrenergic Agonists
App 20080221152 - Heidelbaugh; Todd M. ;   et al.
2008-09-11
Methods Of Preventing And Reducing The Severity Of Stress-associated Conditions
App 20080207628 - Gil; Daniel W. ;   et al.
2008-08-28
Methods Of Preventing And Reducing The Severity Of Stress-associated Conditions
App 20080207627 - Gil; Daniel W. ;   et al.
2008-08-28
Nonsedating Alpha-2 Agonists
App 20080176918 - Chow; Ken ;   et al.
2008-07-24
6-substituted Indole-3-carboxylic Acid Amide Compounds Having Sphingosine-1-phosphate (s1p) Receptor Antagonist Biological Activity
App 20080171772 - Beard; Richard L. ;   et al.
2008-07-17
4-(Heteroaryl-methyl and substituted heteroaryl-methyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
Grant 7,399,868 - Heidelbaugh , et al. July 15, 2
2008-07-15
4-(Condensed cyclicmethyl)-imidazole-2-thiones acting as .alpha..sub.2 adrenergic agonists
Grant 7,396,849 - Heidelbaugh , et al. July 8, 2
2008-07-08
Alpha-2b Receptor Agonist And Anticonvulsant Compositions For Treating Chronic Pain
App 20080153874 - Gil; Daniel W. ;   et al.
2008-06-26
Alpha-2 Receptor Pan Agonist And Serotonin-norepinephrine Reuptake Inhibitor Compositions For Treating Chronic Pain
App 20080153808 - Gil; Daniel W. ;   et al.
2008-06-26
Therapeutic and Delivery Methods of Prostaglandin Ep4, Agonists
App 20080132543 - Im; Wha Bin ;   et al.
2008-06-05
Compositions Comprising Nb-Dnj, Ne-Dnj Or D-Glucaro-Delta-Lactam And Their Uses For The Treatment Of Pain And Other Neurological Condittions
App 20080085920 - Donello; John E. ;   et al.
2008-04-10
4-(2-methyl-5,6,7,8-tetrahydro-quinolin-7-ylmethyl)-1,3-dihydro-imidazole-- 2-thione As Specific Alpha2b Agonist And Methods Of Using The Same
App 20080070945 - Heidelbaugh; Todd M. ;   et al.
2008-03-20
Methods and compositions for alleviating pain
Grant 7,345,065 - Gil , et al. March 18, 2
2008-03-18
Heteroaromatic Compounds Having Sphingosine-1-phosphate (s1p) Receptor Agonist Biological Activity
App 20080064872 - Beard; Richard L. ;   et al.
2008-03-13
Nonsedating .alpha.-2 agonists
Grant 7,312,238 - Chow , et al. December 25, 2
2007-12-25
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
Grant 7,276,522 - Heidelbaugh , et al. October 2, 2
2007-10-02
Nonsedating .alpha.-2 agonists
Grant 7,141,597 - Chow , et al. November 28, 2
2006-11-28
Treating pain using selective antagonists of persistent sodium current
Grant 7,125,908 - Ehring , et al. October 24, 2
2006-10-24
Method for treating ocular pain
Grant 6,294,553 - Gil , et al. September 25, 2
2001-09-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed